📊 PTN Key Takeaways
Is Palatin Technologies Inc. (PTN) a Good Investment?
Palatin Technologies faces existential financial distress with revenue collapsing 100% year-over-year to $9M while incurring -$2.7M operating losses and -$6.4M negative free cash flow. Despite a $14.5M cash position providing ~2.3 years runway, the complete revenue decline and persistent unprofitability in the pharmaceutical sector indicate fundamental business failure with minimal recovery prospects.
Why Buy Palatin Technologies Inc. Stock? PTN Key Strengths
- Strong cash position of $14.5M with zero long-term debt providing financial flexibility
- Low capital intensity with minimal capex ($12.8K) reducing ongoing infrastructure burden
- Solid short-term liquidity with 2.76x current and quick ratios ensuring near-term solvency
PTN Stock Risks: Palatin Technologies Inc. Investment Risks
- Catastrophic revenue collapse (-100% YoY) indicating product failure or market exit in critical pharmaceutical business
- Negative free cash flow of -$6.4M annually with only ~2.3 years of cash runway before potential insolvency
- Persistent operating losses (-$2.7M) with -29.8% operating margin demonstrating unsustainable business model
- Zero insider Form 4 filings in 90 days suggesting complete absence of management confidence
- Pharmaceutical sector exposure without apparent revenue-generating products or viable pipeline
Key Metrics to Watch
- Monthly cash burn rate and remaining runway duration to insolvency
- Sequential quarterly revenue trends and any pipeline advancement announcements
- Form 4 insider transaction filings indicating management confidence in turnaround
Palatin Technologies Inc. (PTN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.76x current ratio provides a solid financial cushion.
PTN Profit Margin, ROE & Profitability Analysis
PTN vs Healthcare Sector: How Palatin Technologies Inc. Compares
How Palatin Technologies Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Palatin Technologies Inc. Stock Overvalued? PTN Valuation Analysis 2026
Based on fundamental analysis, Palatin Technologies Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Palatin Technologies Inc. Balance Sheet: PTN Debt, Cash & Liquidity
PTN Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Palatin Technologies Inc.'s revenue has grown significantly by 3,706% over the 5-year period, indicating strong business expansion. The most recent EPS of $-101.16 indicates the company is currently unprofitable.
PTN Revenue Growth, EPS Growth & YoY Performance
PTN Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $116.0K | -$2.4M | $-1.47 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Palatin Technologies Inc. Dividends, Buybacks & Capital Allocation
PTN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Palatin Technologies Inc. (CIK: 0000911216)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PTN
What is the AI rating for PTN?
Palatin Technologies Inc. (PTN) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PTN's key strengths?
Claude: Strong cash position of $14.5M with zero long-term debt providing financial flexibility. Low capital intensity with minimal capex ($12.8K) reducing ongoing infrastructure burden.
What are the risks of investing in PTN?
Claude: Catastrophic revenue collapse (-100% YoY) indicating product failure or market exit in critical pharmaceutical business. Negative free cash flow of -$6.4M annually with only ~2.3 years of cash runway before potential insolvency.
What is PTN's revenue and growth?
Palatin Technologies Inc. reported revenue of $9.0M.
Does PTN pay dividends?
Palatin Technologies Inc. does not currently pay dividends.
Where can I find PTN SEC filings?
Official SEC filings for Palatin Technologies Inc. (CIK: 0000911216) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PTN's EPS?
Palatin Technologies Inc. has a diluted EPS of $-1.47.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is PTN a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Palatin Technologies Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is PTN stock overvalued or undervalued?
Valuation metrics for PTN: ROE of -22.6% (sector avg: 15%), net margin of -28.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy PTN stock in 2026?
Our dual AI analysis gives Palatin Technologies Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PTN's free cash flow?
Palatin Technologies Inc.'s operating cash flow is $-6.4M, with capital expenditures of $12.8K. FCF margin is -71.8%.
How does PTN compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -28.9% (avg: 12%), ROE -22.6% (avg: 15%), current ratio 2.76 (avg: 2).